Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5)

Rasmus W Licht, Danish University Antidepressant Group

Research output: Contribution to journalJournal articleResearchpeer-review

7 Citations (Scopus)
Original languageEnglish
JournalJournal of Affective Disorders
Volume148
Issue number2-3
Pages (from-to)286-290
Number of pages5
ISSN0165-0327
DOIs
Publication statusPublished - 2013
Externally publishedYes

Keywords

  • Antidepressive Agents
  • Citalopram
  • Clomipramine
  • Denmark
  • Depressive Disorder
  • Double-Blind Method
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Placebos
  • Secondary Prevention
  • Severity of Illness Index
  • Treatment Outcome

Fingerprint Dive into the research topics of 'Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5)'. Together they form a unique fingerprint.

Cite this